Studied primarily for their ability to bind and internalise modified lipoproteins and have been implicated in the development of atherosclerosis and other macrophage-associated functions
Cambridge BioScience offers the latest Hycult Biotechnology (HBT) novel antibodies for scavenger receptor research.
One of the highlights of the range is the unique antibody to lectin-like oxidised LDL-receptor-1.
This is believed to be the first commercial antibody to LOX-1.
Scavenger receptors have been studied primarily for their ability to bind and internalise modified lipoproteins and have been implicated in the development of atherosclerosis and other macrophage-associated functions. They also function as pattern recognition receptors for a wide variety of pathogens indicating a potential role in host defence.
